Click Here to return To Results

 

Extrathymic Tumors in Patients With Myasthenia Gravis, A 35-Year Retrospective Study The Neurologist 12:53-55, Wakata,N.,et al, 2006 See this aricle in Pubmed Article Abstract Cancer risk in patients with myasthenia gravis is 2.6%, similar to that of the general population in Japan. We neurologists need to be aware that prolonged immunosuppression may favor the development of malignancy.

Related Tags

(click to filter results - removes previous filter) azathioprine carcinoma immunosuppressive agents myasthenia gravis

Click Here to return To Results